Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page
- Check7 days agoChange DetectedAdded the MeSH term Malignant lymphoma, large B-cell, diffuse and a new external resource entry for the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check57 days agoChange DetectedA minor site revision update was added (Revision: v3.4.2) and the prior government funding/status notice was removed (Revision: v3.4.1), with no impact on study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedA site-wide funding/status notice was added and a PubMed publication reference related to the study was included. These updates do not change the core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check71 days agoChange DetectedGlossary content is now displayed on the page. Metadata labels were updated to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.